ArticleWorld journal of otorhinolaryngology - head and neck surgery2026
Inflammatory Markers-Based Surgical Pathological Complete Response Prediction After Neoadjuvant Immunotherapy Combined With Chemotherapy in Head and Neck Squamous Cell Carcinoma.
Article in World journal of otorhinolaryngology - head and neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the predictive value of blood routine parameters for surgical pathological complete response (PCR) following neoadjuvant immunotherapy combined with chemotherapy (NICC) in patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC). Methods: We retrospectively analyzed patients with LAHNSCC who underwent NICC and the subsequent surgery at our hospital between May 2021 and November 2024. PCR included PCR of the primary tumor site (PPCR), PCR of the metastatic lymph node (LPCR), and PCR of both the primary tumor site and metastatic lymph node (PLPCR). Results: Of the 109 patients assessed, 41 (37.6%) achieved PPCR and 57 (52.3%) achieved LPCR. Of these, 29(26.6%) patients achieved PLPCR. LPCR did not exhibit any significant associations with the clinical parameters ( Conclusions: NLR may serve as valuable predictors of PCR following NICC in LAHNSCC. Specifically, patients with NLR ≤ 2.115 may have a higher likelihood of achieving PPCR and PLPCR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.